Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Effects of Modafinil on Cognitive Functioning and Emotional Processing in Patients with Remitted Depression

Trial Profile

Effects of Modafinil on Cognitive Functioning and Emotional Processing in Patients with Remitted Depression

Status: Completed
Phase of Trial: Phase IV

Latest Information Update: 08 Jun 2016

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Modafinil (Primary)
  • Indications Depression
  • Focus Therapeutic Use

Most Recent Events

  • 11 Feb 2016 Accural to date is 100% as reported by United Kingdom Clinical Research Network.
  • 11 Feb 2016 Status changed from recruiting to completed as reported by United Kingdom Clinical Research Network.
  • 14 Nov 2015 Accrual to date is 95% according to the United Kingdom Clinical Research Network record.

You need to be a logged in or subscribed to view this content Request demo (opens in a new window)

If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top